Detection of Bony Metastases: Preliminary Study of 18F-Fluoride Positron Emission Tomography/Computed Tomography (PET/CT)
Not Applicable
Recruiting
- Conditions
- Detection of bony metastasisCancer - Bone
- Registration Number
- ACTRN12609000120279
- Lead Sponsor
- ational Science Council, Taiwan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1. patients with histological diagnosis of breast cancer, head and neck cancer, lung cancer, gynecological cancer, genitourinary cancer, or colorectal cancer
2. high risk of or suspicious/equivocal findings for bony metastasis by conventional studies
Exclusion Criteria
1. Patients with more than one type of cancer
2. patients with pregnancy or breast-feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The presence or absence of bony metastasis as assessed by histological proof and/or clinical follow-up by the attending professional oncologist at out-patient clinic every 3 months with the aid of related imaging examinations such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and traditional bone scan (which is different from the 18F-Fluoride Positron Emission Tomography/Computed Tomography as described in the intervention field) at the attending professional oncologist's discretion[This outcome will be assessed every 3 months post-intervention until 1 year for each participant (this outcome is not measured at baseline)]
- Secondary Outcome Measures
Name Time Method Overall survival as assessed by questionnaires[On a yearly basis until death];Clinical impact (treatment change due to 18F-Fluoride PET/CT) as assessed by surveys for the professional oncologists for all participants[after one year of follow-up for each participant]